It has been reported that the ill vivo maturation of Langerhans cells after hapten painting is mediated by IL-II3 while Langerhans celllnaturation after ill IIU,'O culture is mediated by granulocyte-macrophage colony-stimulating factor (GM-CSF). To clarify the reason for this discrepancy, we exanlined the expression ofIa antigen and several co-stitnulatory molecules on Langerhans cells that were activated by ill .fit,'o culture, by hapten painting, or by an intradermal injection of several cytokines. Both cultured Langerhans cells and those activated by hapten painting increased the expression of la antigen and all the co-stimulatory molecules (i.e., intercellular adhesion molecule-I [ICAM-I], B7-I, B7-2, and CD40). In contrast, an intradermal injection of interleukin-113 (IL-If3) or tumor necrosis factor-a (TNF-a) increased the expression of Ia antigen, ICAM-I, B7-2, and CD40, but not that ofB7-1. These data indicate that R ecentl y it ha s bee n demonstrated , b y several authors [1. 2,1 4,23,24,29 J that La n ge rhan s cell s can be m aturated both ill IIi"O and ill "ifro, Maturated Lan ge rhan s ce ll s in crease the ir expression of major histocompatibility co mp lex (M HC) class II anti gcn (Ag) and show en han ced antigcn presc n ting fun ction [4.21 ,30]. W itmer-Pack cf 111 [32J and )-ieuAer ef III [1 3] have d emon strated that the maturati o n of Langerhans cell s that occu rs after ill IIifm short-term c ulture is m ediated by g ranulocytc-ma crophagc colon ysti mulating factor (GM-CSF) and that inte rl cukin-1 (rL-l) enhances the e ffcct of GM-C SF. On the other hand, Enk cf 111 [10] havc fo und that the increase in Langcrhan s cell-derivcd IL-1 f3 mRNA signal strength is the first even t in the process of ill I,ill" maturatio n of Langerhans cell s aftcr hapte n painting . In addition, they showed that the c utaneou s inj ec tion of IL-1 f3 res ul ted in increased exp ress io n of M.H C class II Ag .. Ild en hanced antige n prese ntin g fun ction by Langerhans ccll s suggesti ng that ill lIillo ma turation o f La ngerhans ce ll s th;lt occ urs after hapte n painting is mediated by I L-I f3 18]. T herefore, if Langerhans cell maturation induced by the c utan eo us injection of IL-'l f3 is the sa me ph en om-Ma nu script rcceivcd Fcbruary II , 1995; rev ised Octobe r 26 , 1995; acc eptcd for publication October 311 . 1995. Reprint requcsts to: I r. SctSLlya Aiba. Departll1 e nt of DerIllatol ogy, To h ok u Un iversity Schoo l of Mcdicin c . 1-1, Sciryo-ma c hi, Aoba-k u . Sendai. 980-77 , J apan. Abbrev iation: TNCU. 2.4 .G-trinitroch lorobcnzenc.
It has been reported that the ill vivo maturation of Langerhans cells after hapten painting is mediated by IL-II3 while Langerhans celllnaturation after ill IIU,'O culture is mediated by granulocyte-macrophage colony-stimulating factor (GM-CSF). To clarify the reason for this discrepancy, we exanlined the expression ofIa antigen and several co-stitnulatory molecules on Langerhans cells that were activated by ill .fit,'o culture, by hapten painting, or by an intradermal injection of several cytokines. Both cultured Langerhans cells and those activated by hapten painting increased the expression of la antigen and all the co-stimulatory molecules (i.e., intercellular adhesion molecule-I [ICAM-I], B7-I, B7-2, and CD40). In contrast, an intradermal injection of interleukin-113 (IL-If3) or tumor necrosis factor-a (TNF-a) increased the expression of Ia antigen, ICAM-I, B7-2, and CD40, but not that ofB7-1. These data indicate that R ecentl y it ha s bee n demonstrated , b y several authors [1. 2,1 4,23,24,29 J that La n ge rhan s cell s can be m aturated both ill IIi"O and ill "ifro, Maturated Lan ge rhan s ce ll s in crease the ir expression of major histocompatibility co mp lex (M HC) class II anti gcn (Ag) and show en han ced antigcn presc n ting fun ction [4.21 ,30] . W itmer-Pack cf 111 [32J and )-ieuAer ef III [1 3] have d emon strated that the maturati o n of Langerhans cell s that occu rs after ill IIifm short-term c ulture is m ediated by g ranulocytc-ma crophagc colon ysti mulating factor (GM-CSF) and that inte rl cukin-1 (rL-l) enhances the e ffcct of GM-C SF. On the other hand, Enk cf 111 [10] havc fo und that the increase in Langcrhan s cell-derivcd IL-1 f3 mRNA signal strength is the first even t in the process of ill I,ill" maturatio n of Langerhans cell s aftcr hapte n painting . In addition, they showed that the c utaneou s inj ec tion of IL-1 f3 res ul ted in increased exp ress io n of M.H C class II Ag .. Ild en hanced antige n prese ntin g fun ction by Langerhans ccll s suggesti ng that ill lIillo ma turation o f La ngerhans ce ll s th;lt occ urs after hapte n painting is mediated by I L-I f3 18]. T herefore, if Langerhans cell maturation induced by the c utan eo us injection of IL-'l f3 is the sa me ph en om-Ma nu script rcceivcd Fcbruary II , 1995; rev ised Octobe r 26 , 1995; acc :441-445, 1996 en on as that occurring on Langerhans cell s that mature after hapte n painting, the re remains a di sc repancy in the reported beh avio r of cy tolcin es that mediate the m aturation of L1ngerhans cell s between ;11 pilll) and ill ";(1"0. It is also we l1 known that accessory molec ul es are rcquired for antigen-presenting cells to stimulate T cell s 17,15,22,28,3 1]. T hcrefore, in this study examining the phenotypic chan ges in Langerhans cell s maturated ill I/ifro aud ill II illO, we hav c analyzed the contribution of diffe re n t cytolcincs in the maturatio n process of Langerhans cell s unde r ill l,iv(I and ill IIifm situ ations.
MATERJALS AN I METHODS
M.iee Specifi c pathogen-fi'ee I" mal c OAU3 /c AJclmi ce. 8-10 wk of age. were o btain cd fro lll the Institute of Expcl;m ental Animal s. Tohoku Unive rsity School of Mcdicine, Antibodies We uscd thc followi n g m o n oclonal antiboo ies (MoAbs) for in1ll'11In osta inin g : anti-intcrcc llula r ad hes ion mole cule-I (ICAM-I) (KA T-I ). anti-CD-IO (HM-40-3) (gifts fi'ol11 Dr. Yagita and Dr. Kato. Dcpartment of Iml11un o logy. Julltcndo University. Tokyo . Japan). aI10-U7-1 (07 I B01). <I nti-07-2 (GL-I) (PharMingell. Sail Diego. C Al, ano fluorcs cein isothiocyanate (FITC)-conjugated an ti-I-E (d. k haplotypcs) (l'hmMingen) MoAbs . Phycoe r),tltrin-conju gated ami-rilt IgG (TAGO, UlII'lingill1lc . CAl o r bioon ylatcd anti-ham ster I~G (Vcc tor Labonn:ories. 13l11'lin ga m e. CAl followed by phycocrythrin -conjugated avidi n (Uec ton-D ickinso ll. Sa il J ose. CAl wcre used as second-stc p rl'agcnts , Isotype-lI1atched ral con trol Ab (lgG 2 • and IgG 21 ,). halllste r IgG and FITC-colljuga ted rat control IgG o h Ab (Ph arMingcn) ,vere llsed <1 S negative co ntro ls. In o rd e r to cxa nlin c the clrccts of anti-cytokinc Abs 011 th e upreguiation of adhesion molec ul es or 0022-202X / 96 /S10,50 • Co pyri ght Ii) 1996 by T hc Society for Ill vestigati ve l)e rInato lob')'. In c.
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MH C class JI Ag by ill " itro cul tured Langerh"n s ce ll s, we used goat anti-murin e GM-CSF, anti-murin e tUl110r necrosis f.,cto r-CI' (TNF-a). and anti-1I1urin e IL-1 {3 Ab frol11 R&D Syste m (M inn eapo li s. MN). Purifi ed Goat Ig was purchased frolll ZY MED Laboratories. Inc. (Sa n Francisco. CAl.
Chcmicals and Cytokincs 2.4 .6-trinitrochl o robc nzc nc (TNCB) was purchased from Tokyo Kase i Laborato ries (Tokyo, Japan) and wa s IHcpared in acetone/oli ve o il (1 :4) at 3% fi nal conce ntration. R.ecombi nan t murin e GM-CSF, recombinant murin e TNF-CI'. and recombinant murin e IL-1 (3 wcre all obtain ed frol11 R &D Systcm . T hese cytokincs were suspen ded in ph os phate-buffered salin c (PHS) co ntaining 0.2'!!' ) bovine serum a lbumin (BSA).
Chcmical Trcatmcnt a nd Cytolcinc Injcction After anesthetized with )I-h ydroxybu tyri c acid (Sigma C hemi cal Co .. St. Lo uis. MO) , BALB/c mi ce we re inj ected illtrade rmall y in each ear with 50 o r 250 Ilg of recombin ant murin e rG M-CSF, 50 ng of TNF-u, o r 50 ng of lL-1 {3. Another gro up of mice werc inj ected w ith PBS con ta inin g 0.2% BSA as a negative control. As a positive control, other mice wcre pain ted on t h c ca rs with 3% TNCI3 in acctone/oLlve oil (1 :4) . In most ex perim en ts. epjdermal ce ll suspens ions wcre prepared 16 h after the treatmcnts.
Preparation of Epidermal Cell Suspcnsion Epidermal cell s uspensions werc prepa red by treating the split skj n sheets of cars of nontrca ted o r chcrni caJl y treated mi ce, or those inj ected w ith va ri o us cytokj nes with 1000 U/ 1111 Dispa se (Sanko Pure C hemi cal In c., Tokyo, J apan) in RPMf-1640 sup plemented w ith 1 % fetal bovine se rum fo r 2 h as described prev io usly r3.19] . In order to ob tain a Langerh ans cell-enrich ed popu lation, these cpid crma l cell suspe nsions were applied onto Lympho lite M density g radien ts (Ccdarlan e Laborato ri es Limited. Ca nada ) and centr ifuged at 1400 rpm fo r 10 111in nt roonl te l1lpCnlturc. T he in ter face cell s we re recovered. whi ch co ntain ed 5-10'10 I-E-positiv e cell s (La nge rhans) in addition to keratin ocytes.
Langerhans Cell Culture R .. PMI 1640 m edium supplem ented with 10'X. fe tal bov ill e serum , 2 mM glutami ne (G ibco Laboratori es . C hagrin Fa ll s, OH). peni cillin. streptom ycin and fun gizone antibioti c so lu tio n (Gibco) . non-essentia l amin o acid so luti on (G ibeo) . sodium p yruva te solution (Gibeo). 10 111M N-2-hydroxyethylpi pera zine-N '-2-e thancsulfon.ic acid buffer solutio n (G ibco), 5 X 10 -' M 2-ME . and 1 p,g/m l ind omethac in (Sigma) (comp lete medium) was used for the culture . Enriched Langerhan s cell suspcns ions ( 1.5 X 10" / ml) were cultured in the comp lete m e dium usin g 24-well plate (Falcon) in the presence of goat Ig or MoAb to GM-CSF, TNF-CI' , o r I L-l {3. T he surface ex pression of various adhesio n molecul es oil Lan gerhans ccll s was exam ined by flo w cy tom etry 72 h aftc r culture.
F low CytOJnetry For fl ow cytometry, cell suspen sions were first in cubated with vari ous M oA bs to m ouse adhesion molecul es o r isotype-match ed rat or ham ster control Abs fo r 30 min on icc, washed w ith PllS s upp lem ented with 1% feta l bov in e serum and 0.02% N aN , (wa shin g buller) , and rhen in cubated with ph ycoerythrin-conju ga ted anti-rar-Ig (TAGO). Or biotin ylated an ti-hamste r IgG follow cd by phycoe rythrin-conjugate d av id in. After being w" shed with wa shin g buffer, ce lls w ere seriall y treated with 50 /Lg/ml of rat Ig for 10 min and w ith FITe -I E o r FITC-rat co ntrol Ab for 3 0 min on icc. Afte r being was hed agai n, they werc ana lyzed On a FACSc:l n u sin g Lysis " software (Becton Dickjnso n) . LlI1gerh an s cell s as identi fi ed by intense reacti vity with FITC-I:l bel ed anti-I -E MoAb were gated for the a nalysis of MI-I C class " Ag or costimulatory mo lecu le express ion. and 1110 re t han 3.000 eve nts were acq uired for each ana lysis. Mea n flu oresce nce i ntensity (MFI) was dctcrmin ed for e<l ch surface mo lec ul c. "nd the cll:c cts of cytokines were eva lu ated by percent<l ge M PI as c<llculatcd usin g th e to ll ow in g form ul a 15,6,171: !CA M-l. B7-2, and CD40 co mpared with tho se inj ected w it h 0.2% bovine se rum a lbumin in PBS as contro l, w hil e no sign ifi ca nt cha n ges w e re recogniza bl e o n th e ir ex pressio n of B7-1. Intradermal inj e ction of G M-CSF in two diffe re nt doses, e ith e r 50 or 250 n gl ear, c ou ld n ot affect tl1e exp ress io n on Langerhans ce ll s of a\l the molec ul es we studi e d. Furthermore, we p erfo rm e d a kjneti c stud y in which we prepared e pide rm a l ce ll su spe n sio n s at th e va ri o u s time inte rval s (i.e., 1,4,8, 1 6, and 48 h) after G M-CSF, IL-1 f3 inj ection , or TNCB treatment (Fig 3) . We found that th e m ost re markabl e phenotypic c han ges o n Langerhans ce Us w e re observ e d at 16 h afte r the trea tm e nts a nd that the ph e n otyp Langerhalls cell s. To exclude such a possibility, we injected at first IL-l,8, and at diffe re nt tim e interval s (0, 4, 8, 16 h) thereafter we examined the effect of GM-CSF; however, these combin e d injections did not alter the e ffects of injectin g lL-1,8 alo ne (data not shown).
The Upregulation ofB7-1 Expression on Cultured Langerhans Cells Was Downregulated by Anti-GM-CSF Ab and
Anti-TNF-a Ab From ill 11;'10 study, we co uld not sp ecifY the cytokine(s) that mediate B7-1 upregulation . Thus, we examin ed the effects of Abs to several cyto kin es o n th e upregul atio n ofB7-1 , MHC class II Ag, and other accessory molecul es o n Langerhans cells culture d for 72 h (Fig 4) . When we added 20 /-Lg/ ml of anti-GM-CSF o r anti-TNF-a Ab to the c ul ture of epidermal cells, the expression ofB7-1 on Langerhans cell s was inhibited , whereas the additi o n o f 20 /-Lg/m l of anti-IL-1,8 Ab could not suppress its expression a t all. In addition, only anti-G M-CSF Ab exerted a partial inhibito ,-y effect on the upregulation of B7-2 exp ressio n. Non e of the A bs to GM-CSF, TNF-a, or IL-l,8 c hanged the expression of MHC class II Ag, lCAM-l, o r CD40.
DISCUSSION
In tius st ud y, we have d e monstrated that Langerhans cells m aturate d ill lIillo by hapte n painting also upregul ate the co-stimulato ry mo lecul es as well as MHC class II Ag. In other words, Langerhans cells that mature ill v ivo seem to b e almost identical with those that mature ill lIill'O, although the latter express th e co-stimulatory molecul es much more than the former.
We did d emonstrate that the pheno type of Langer hans cells after intrad e rmal injection ofIL-1,B was diffe re nt from that of Langer hans cells after hapten painting. Langerhans ce LIs o btained after intradermal injection of IL-l,8 did not upregulate B7-1, whereas ;11 11 ;110 hapten treatm en t d efinite ly increase d 137-1. This observ ed differen ce indicates that the si mpl e inj ec tion of I L-l (3 co uld not be a substitute for the m ed iato rs in vo lved in L:lJ1gerh ans cell m aturatio n after h apten painting and th at other signal s arc re quire d for the full simulatio n of Langerhans cells. T herefore, we next examined whether TNF-a o r GM-CSF, which we re suggested to affect Langerhans cell fun ction ill 'Iil ro 1' 13, 18,32), a uld upreglllate the exp ressio n of B7-1.. Unexpectedly, we co uld not recogni ze the upregul atio n ofB7-1 expression eithe r by the in trade rm al injectio n of 50 o r 250 ng/ea r of GM-CSF, o r by th at of T NF-a. O n the other hand , anti-GM-CSF Ab a nd , altho ug h less efficie ntly, anti-TNF-a Ab co uld suppress the llpregul atio n of137-1. o n c ulture d La n ge rh an s cell s, sugges tin g that G M -CSF an d T N F-a m e diate the in crease in expressioll of 137-1 o n Langerhans cell s ill vitro . These ill "i llO an d ill II ill'O data suggest that La ngerhans ce Us require both IL-l,8 and GM-CSF for the ir fu ll maturation; th e former is responsible for the llpregllla tio n of MHC class II Ag, ICAM-l, 137-2, and CD40, w hik the latter is fo r that of 137-1 .
When we assum e, however, that GM-CSf upregllJate th e express ion ofB7-1 , w hj le LL-l ,8 in crease the e xpression of MHC class II Ag, (CAM-I , 137-2, and CD40, at least two qu es tions ari se. The first is w h y we co uld not recogni ze the upregul atio n ofB7-1 afte r GM-CS,F il'jection. We ca n think of three possible explanations. T he first o ne is that the amount ofGM-CSF we inj ected is too small to induce th e phe notypic chan ges of La nger hail s ce ll s. To excl ud e this possibility, w e m easure d GM-CSF co ncen tration of the culture supe rna ta nt of epide rmal cells , in w hi ch B7-1 upreguJ ation o n Langerhans cell s was induced . T he ave ra ge GM-CSF con centration in re peate d expe rim en ts ran ged fi-om 400 to 500 pg/ ml (data not shown), w he reas we injected 1 o r 5 /-Lg / ml, far exceeding amounts ofGM-CSF in OUl' experiments. T he second possible explanation is that GM-CSF actuall y ca nn ot reac h o r bind th e receptors on epiderm al Lan gerha ns cell s. It is well known that g lycosa min oglyca ns bind to GM-CSF [11 ,25] . The g lycosa rnin oglyca n that is abundantly presen t in the dermis as we ll as at the de rm o-epide rmal junction m ay bind to GM-CSF to inhibit its furthe r difli.lsioll to >t:: h a ve fo und th at in c reased IL-l{3 mRNA sig na l is acc lImuloted in Lange rh ans ce lls as earl y as '/ 5 min ;rfce r e xpos ure to contact a ll e rgens. T h erefore , it is speculolted t hat the productio n of lL-lf3 a lso starts in Lange rh ans cell s at an extre m ely earl y stage in culture . It took abo u t 3 h fo r us to prepare Langerhans ce ll-enri ched po pula tio n and to sta rt th eir c ulture with anti-I L-l {3 A b. T hus, "'~ c ann o t exclude t he possibility that durin g this timc in terval. La nge rh ans cell s aI'e alre ad y stimula te d to inc re ase MHC cl ass II Ag, IC AM.-1 , 11 7-2. and C D 40 express io n .
As fo r the I'egulatio n of D7-2 express io ll, we fo und th at an ri-G M-CS F Ab slightl y bu t clearl y inhibi ted its a ug m entatio n in o ur ill 
